Molecular imaging of human ACE-1 expression in transgenic rats

JACC: Cardiovascular Imaging

Volumn 5, Issue 4, 2012, Pages 409-418

  Dilsizian, Vasken ^a   Zynda, Todd K ^b   Petrov, Artiom ^d   Ohshima, Satoru ^b   Tahara, Nobuhiro ^b   Haider, Nezam ^d   Donohue, Amanda ^b   Aras, Omer ^a   Femia, Frank J ^c   Hillier, Shawn M ^c   Joyal, John L ^c   Wong, Nathan D ^b   Coleman, Tomika ^a   Babich, John W ^c   Narula, Jagat ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c A Subsidiary of Lantheus Holdings   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin converting enzyme; heart failure; lisinopril; radionuclide imaging; remodeling; SPECT CT

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; MESSENGER RNA; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; HEART FAILURE; HEART MUSCLE; HUMAN; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOISOTOPE DISTRIBUTION; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENIC RAT; WILD TYPE;

ANIMALS; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA; UP-REGULATION;

EID: 84859612948     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.10.008     Document Type: Article

References (41)

1. M. Paul, Y.M. Pinto, H. Schunkert, D. Ganten, M. Bhm Activation of the renin-angiotensin system in heart failure and hypertrophy - studies in human hearts and transgenic rats Eur Heart J 15 1994 63 67
2. X.L. Tian, Y.M. Pinto, O. Costerousse, W.M. Franz Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats Hum Molec Genetics 13 2004 1441 1450 (Pubitemid 39023052)
3. R. Studer, H. Reinecke, B. Mller, J. Holtz, H. Just, H. Drexler Increased angiotensin-I converting enzyme gene expression in the failing human heart Quantification by competitive RNA polymerase chain reaction J Clin Invest 94 1994 301 310
4. R. Kumar, V. Singh, K.M. Baker The intracellular renin-angiotensin system: implications in cardiovascular remodeling Curr Opin Nephrol Hypertens 17 2008 168 173 (Pubitemid 351253042)
5. H. Yamagishi, S. Kim, T. Nishikimi, K. Takeuchi, T. Takeda Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats J Mol Cell Cardiol 25 1993 1369 1380 (Pubitemid 24003843)
6. M.A. Pfeffer, E. Braunwald, L.A. Moyé Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
7. H. Schunkert, V. Dzau, S.S. Tang, A.T. Hirsch, C.S. Apstein, B.H. Lorell Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy Effects on coronary resistance, contractility, and relaxation J Clin Invest 86 1990 1913 1920
8. K.T. Weber, C. Brilla Pathological hypertrophy and cardiac interstitium Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1991 1849 1865
9. P. Anversa, W. Cheng, Y. Liu, A. Leri, G. Redaelli, J. Kajstura Apoptosis and myocardial infarction Basic Res Cardiol 98 1998 8 12 (Pubitemid 29008240)
10. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
11. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
12. R. Baliga, J. Narula Pharmacogenomics of congestive heart failure Med Clin North Am 87 2003 569 578 (Pubitemid 36388726)
13. A.L. Taylor, S. Ziesche, C.W. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
14. V. Dilsizian, W.C. Eckelman, M.L. Loredo, E.M. Jagoda, J. Shirani Evidence for tissue angiotensin-converting-enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique J Nucl Med 48 2007 182 187 (Pubitemid 47555341)
15. Y. Chandrashekhar, J. Narula Exposing ACE up the sleeve J Nucl Med 48 2007 173 174
16. Y.H.C. Lee, D.O. Kiesewetter, L. Lang Synthesis of 4-[18F] fluorobenzoyllisinopril: a radioligand for angiotensin-converting enzyme (ACE) imaging with positron emission tomography J Label Cpd Radiopharm 44 Suppl 2001 268 270
17. D.R. Hwang, W.C. Eckelman, C.J. Mathias, E.W. Petrillo Jr., J. Lloyd, M.J. Welch Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18- fluorocaptopril - probing the ACE activity in vivo by positron emission tomography J Nucl Med 32 1991 1730 1737
18. P.L. Hurst, C.J. Lovell-Smith Optimized assay for serum angiotensin-converting enzyme activity Clin Chem 27 1981 2048 2052 (Pubitemid 12194441)
19. F.J. Femia, K.P. Maresca, S.M. Hillier Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression J Nucl Med 49 2008 970 977 (Pubitemid 351793438)
20. H.M. Neels, S.L. Scharpe, M.E. Van Sande, R.M. Verkerk, K.J. Van Acker Improved micromethod for assay of serum angiotensin converting enzyme Clin Chem 28 1982 1352 1355 (Pubitemid 12125073)
21. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method Methods 25 2001 402 408 (Pubitemid 34164012)
22. N.M. Hooper, A.J. Turner An ACE structure Nat Struct Biol 10 2003 155 157 (Pubitemid 36297981)
23. D. Coates The angiotensin converting enzyme (ACE) Int J Biochem Cell Biol 35 2003 769 773 (Pubitemid 36379317)
24. V.J. Dzau, K. Bernstein, D. Celermajer Pathophysiologic and therapeutic importance of tissue ACE: a consensus report Cardiovasc Drugs Ther 16 2002 149 160 (Pubitemid 34787797)
25. R.B. Perich, B. Jackson, C.I. Johnston Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme Eur J Pharmacol 266 1994 201 211
26. T. Unger, P. Gohlke Converting enzyme inhibitors in cardiovascular therapy: current status and future potential Cardiovasc Res 28 1994 146 158 (Pubitemid 24092762)
27. J.W.H. Verjans, D. Lovhaug, N. Narula Noninvasive imaging of angiotensin receptors after myocardial infarction J Am Coll Cardiol Img 1 2008 354 362 (Pubitemid 351676844)
28. S.W. Van den Borne, S. Isobe, J.W. Verjans Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction J Am Coll Cardiol 52 2008 2017 2028
29. S.W.M. Van den Borne, S. Isobe, R. Zandbergen Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling J Am Coll Cardiol Img 2 2009 187 198
30. J.W. Verjans, S. Wolters, W. Laufer Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging J Nucl Cardiol 17 2010 1065 1072
31. M. Nahrendorf, K. Hu, S. Frantz Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction Circulation 113 2006 1196 1202
32. M. Nahrendorf, E. Aikawa, J.L. Figueiredo Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction Eur Heart J 29 2008 445 454 (Pubitemid 351264174)
33. R. Garg, S. Yusuf Collaborative Group of ACE Inhibitor Trials Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
34. T.D. Giles, R. Katz, J.M. Sullivan Short-and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure J Am Coll Cardiol 13 1989 1240 1247 (Pubitemid 19114195)
35. S.G. Foy, I.G. Crozier, J.G. Turner Comparison of enalapril versus captopril on left ventricular function and survival 3 months after acute myocardial infarction (the "PRACTICAL" study) Am J Cardiol 73 1994 1180 1186
36. H. Wienbergen, R. Schiele, A. Gitt Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction Am J Cardiol 90 2002 1045 1049 (Pubitemid 35335591)
37. L. Pilote, M. Abrahamowicz, E. Rodrigues Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 141 2004 102 112
38. L. Pilote, M. Abrahamowicz, M. Eisenberg, K. Humphries, H. Behlouli, J.V. Tu Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure Can Med Assoc J 178 2008 1303 1311 (Pubitemid 351678353)
39. S.L. Bacharach Positron Emission Tomography V. Dilsizian, G.M. Pohost, Cardiac CT, PET, and MR 2nd Ed. 2010 Wiley-Blackwell Hoboken, NJ 3 29
40. 13N-Ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization J Am Coll Cardiol 33 1999 678 686
41. P. Perrone-Filardi, S.L. Bacharach, V. Dilsizian Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease J Am Coll Cardiol 23 1994 608 616 (Pubitemid 24074937)